Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Planned sale Sr VP, Research & CSO sold 3,334 shares at $18.00 ($60,012)
  10. 4 Planned sale Senior VP and General Counsel sold 76,251 shares at $16.50 ($1,258,142)
  11. 4 Planned sale Sr VP, Research & CSO sold 13,316 shares at $15.00 ($199,740)
  12. 4 Planned sale Sr VP, Research & CSO sold 13,316 shares at $12.00 ($159,792)
  13. 4 Planned sale Sr VP, Research & CSO sold 18,880 shares at $10.08 ($190,310)
  14. 4 Open-market buy 10% owner bought 150,000 shares at $4.46 ($669,585)
  15. 4 Open-market buy 10% owner bought 200,000 shares at $5.26 ($1,052,840)
  16. 4 Open-market buy Director bought 15,000 shares at $4.91 ($73,650)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 25 · 484 filings